Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-25-027065

Options or other derivatives

  • Chief Operating Officer acquired 32,413 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jacobson Mark L. Chief Operating Officer 2025-02-21 Grant or award · Employee Stock Option (Right to Buy) +10,875 10,875 D
Jacobson Mark L. Chief Operating Officer 2025-02-21 Grant or award · Restricted Stock Units +10,769 10,769 D
Jacobson Mark L. Chief Operating Officer 2025-02-24 Grant or award · Performance Stock Units +10,769 10,769 D
Loading xslF345X05/ownership.xml…